Presciently, studies reported 25 years ago demonstrated that PWS adults compared to matched obese controls had significantly reduced first- and second-phase insulin secretion during intravenous glucose tolerance tests [11], attesting to the translational impact of the PWS INS-1 model. This evidence concerns the gene FOXM1 and Prader-Willi syndrome.